It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.
ACCT/FIN_T480: Cannabis: Challenges and Opportunities
In this page you can find
Additional Resources: FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD): Questions and Answers
Development & Approval Process (Drugs)
From an Idea to the Marketplace: The Journey of an Animal Drug through the Approval Process
FDA Center for Drug Evaluation and Research Small Business and Industry Assistance group
CVM Small Business Assistance
National Institutes of Health (NIH): Guidance on Procedures for Provision of Marijuana for Medical Research
National Institute on Drug Abuse's (NIDA) Role in Providing Marijuana for Research
Drug Enforcement Administration - Registration of Manufacturers, Distributors, and Dispensers of Controlled Substances
International Narcotics Control Board: Single Convention on Narcotic Drugs (1961)External Link Disclaimer
National Institute on Drug Abuse (NIDA): Ordering Guidelines for Marijuana and Marijuana Cigarettes
This rule establishes a new part specifying the rules and regulations to produce hemp. This action is mandated by the Agriculture Improvement Act of 2018, which amended the Agricultural Marketing Act of 1946. This rule outlines provisions for the Department of Agriculture (USDA) to approve plans submitted by States and Indian Tribes for the domestic production of hemp. It also establishes a Federal plan for producers in States or territories of Indian Tribes that do not have their own USDA-approved plan. The program includes provisions for maintaining information on the land where hemp is produced, testing the levels of delta-9 tetrahydrocannabinol, disposing of plants not meeting necessary requirements, licensing requirements, and ensuring compliance with the requirements of the new part.
“This Nature Outlook is editorially independent, produced with financial support from a third party. Nature is pleased to acknowledge the financial support of Auxly Cannabis Group Inc. in producing this Outlook."
“Supported content is editorially independent. In this arrangement, a marketing partner pays to align its brand with content already deemed worthy of coverage by our editorial departments. The marketing partner’s involvement is limited to broad agreement on subject matter, governed by a contract. The ultimate approval of any story rests with the editorial department."